THRX

Theseus Pharmaceuticals, Inc. Common Stock
THRX

Overview Fund Activity
Delisted

THRX was delisted on the 13th of February, 2024.

Back to rankings

47 hedge funds and large institutions have $165M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
-4
Holders Change %
-7.84%
% of All Funds
0.76%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
4
Increased
20
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FLSM
Frazier Life Sciences Management
California
$6.96M
2
OM
Opaleye Management
Massachusetts
$2.66M
3
LCM
Lynx1 Capital Management
Puerto Rico
$3.91M
4
FCMV
Foresite Capital Management V
California
$17.9M
5
O
OrbiMed
New York
$85.8M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$12.4M
2
BC
Boxer Capital
California
$2.07M
3
FCM
Farallon Capital Management
California
$0
4
Wellington Management Group
Wellington Management Group
Massachusetts
$0
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$6.54M
Name Holding Trade Value Shares
Change 		Shares
Change %
FA
51
Forefront Analytics
Pennsylvania
– -$74K -13,065 Closed
HNWAG
52
High Net Worth Advisory Group
Florida
– -$5K -800 Closed
1 2
3